ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 24 filers reported holding ALBIREO PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $221,756 | -2.3% | 7,434 | -23.7% | 0.00% | – |
Q4 2021 | $227,000 | -24.3% | 9,743 | +1.5% | 0.00% | – |
Q3 2021 | $300,000 | -15.7% | 9,601 | -5.3% | 0.00% | – |
Q2 2021 | $356,000 | -2.7% | 10,133 | -2.3% | 0.00% | – |
Q1 2021 | $366,000 | -6.6% | 10,373 | -0.7% | 0.00% | – |
Q4 2020 | $392,000 | +45.7% | 10,451 | +29.5% | 0.00% | – |
Q3 2020 | $269,000 | +18.5% | 8,072 | -3.1% | 0.00% | – |
Q2 2020 | $227,000 | -1.3% | 8,329 | +16.9% | 0.00% | – |
Q2 2019 | $230,000 | -14.5% | 7,125 | -5.9% | 0.00% | – |
Q2 2018 | $269,000 | +2345.5% | 7,572 | +2057.3% | 0.00% | – |
Q1 2018 | $11,000 | +22.2% | 351 | -0.3% | 0.00% | – |
Q4 2017 | $9,000 | +28.6% | 352 | +1.1% | 0.00% | – |
Q3 2017 | $7,000 | +600.0% | 348 | +582.4% | 0.00% | – |
Q2 2017 | $1,000 | – | 51 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 198,800 | $5,266,000 | 2.26% |
Perceptive Advisors | 1,960,139 | $51,924,000 | 0.84% |
Chicago Capital, LLC | 502,212 | $13,304,000 | 0.77% |
Birchview Capital, LP | 48,000 | $1,272,000 | 0.77% |
Artal Group S.A. | 500,360 | $13,255,000 | 0.37% |
HEARTLAND ADVISORS INC | 150,000 | $3,974,000 | 0.35% |
Eversept Partners, LP | 78,029 | $2,066,988 | 0.28% |
ArrowMark Colorado Holdings LLC | 956,990 | $25,351,000 | 0.26% |
PA Capital LLC | 12,987 | $344,000 | 0.25% |
Ikarian Capital, LLC | 100,500 | $2,662,000 | 0.21% |